Stock listing
NASDAQ:TEM Tempus AI, Inc. Stock
Home listing (NASDAQ) of Tempus AI, Inc.
Follow Tempus AI, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TEM
$54.04 USD -9.58 (-15.1%)
Close on Nov 20, 2026
- Day range
- $53.26 – $58.35 USDNov 20, 2026
- Volume
- 7.42M sharesNov 20, 2026
- Market cap
- $9.58B USDAt the close on Nov 20, 2026 · price × 177.4M shares outstanding
- 52-week range
- $40.77 – $89.09 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $512.9M USDMedian day 6.24M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TEM · Home | $54.04 USD | -9.58 (-15.1%) | 7,423,785 | $57.99 | $58.35 | $53.26 | $63.62 | Close on Nov 20, 2026 |
| BMV:TEM | $1,143.36 MXN | -28.05 (-2.4%) | 2 | $1,538.00 | $1,538.00 | $1,143.36 | $1,171.41 | Close on Nov 19, 2026 |
| Frankfurt:F3M | €50.69 EUR | -4.01 (-7.3%) | 3,086 | €52.73 | €53.09 | €50.69 | €54.70 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TEM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $54.04 | -9.58 | -15.1% | $57.99 | $58.35 | $53.26 | 7,423,785 | |
| $63.62 | +0.19 | +0.3% | $63.88 | $65.24 | $61.71 | 5,348,138 | |
| $63.43 | -1.33 | -2.1% | $67.12 | $67.31 | $61.79 | 6,141,978 | |
| $64.76 | -6.84 | -9.6% | $69.05 | $69.08 | $64.56 | 4,995,234 | |
| $71.60 | -4.29 | -5.7% | $75.65 | $75.72 | $68.48 | 5,285,693 | |
| $75.89 | -3.54 | -4.5% | $75.11 | $77.70 | $71.61 | 4,804,028 | |
| $79.43 | -1.11 | -1.4% | $83.15 | $85.10 | $79.25 | 4,198,832 | |
| $80.54 | -3.90 | -4.6% | $82.37 | $83.43 | $78.16 | 4,965,707 | |
| $84.44 | +8.39 | +11.0% | $77.60 | $85.75 | $76.43 | 8,106,536 | |
| $76.05 | +5.62 | +8.0% | $70.95 | $76.85 | $70.22 | 6,271,218 | |
| $70.43 | -5.18 | -6.9% | $72.35 | $72.64 | $65.07 | 9,957,595 | |
| $75.61 | -2.19 | -2.8% | $78.74 | $81.60 | $72.75 | 5,914,441 | |
| $77.80 | -0.68 | -0.9% | $80.75 | $84.47 | $77.60 | 6,295,134 | |
| $78.48 | +6.26 | +8.7% | $74.31 | $83.42 | $70.30 | 16,980,865 | |
| $72.22 | -5.62 | -7.2% | $73.49 | $76.65 | $70.86 | 10,418,259 | |
| $77.84 | +1.23 | +1.6% | $75.50 | $78.40 | $75.35 | 4,778,018 | |
| $76.61 | +4.46 | +6.2% | $72.09 | $77.51 | $71.75 | 6,869,177 | |
| $72.15 | +4.99 | +7.4% | $67.18 | $72.89 | $66.50 | 5,066,128 | |
| $67.16 | -0.455 | -0.7% | $67.60 | $68.00 | $64.03 | 3,765,810 | |
| $67.62 | +3.805 | +6.0% | $63.94 | $68.15 | $62.67 | 4,679,300 | |
| $63.81 | -3.95 | -5.8% | $66.10 | $68.29 | $61.51 | 6,204,200 | |
| $67.76 | +1.01 | +1.5% | $66.88 | $68.93 | $66.00 | 3,382,400 | |
| $66.75 | +2.41 | +3.7% | $63.80 | $69.07 | $63.20 | 4,994,500 | |
| $64.34 | -0.38 | -0.6% | $66.38 | $67.70 | $63.50 | 4,176,500 | |
| $64.72 | -6.41 | -9.0% | $70.89 | $72.50 | $63.79 | 6,873,100 | |
| $71.13 | +2.81 | +4.1% | $64.77 | $72.81 | $63.60 | 6,667,500 | |
| $68.32 | +0.10 | +0.1% | $67.00 | $71.35 | $66.35 | 6,064,800 | |
| $68.22 | +0.23 | +0.3% | $67.12 | $68.78 | $66.17 | 4,152,600 | |
| $67.99 | -2.94 | -4.1% | $69.89 | $70.25 | $67.03 | 3,800,300 | |
| $70.93 | +1.65 | +2.4% | $70.20 | $72.96 | $69.20 | 6,273,300 | |
| $69.28 | -1.07 | -1.5% | $68.86 | $69.75 | $66.71 | 7,476,400 | |
| $70.35 | -1.63 | -2.3% | $70.10 | $73.09 | $68.66 | 9,013,700 | |
| $71.98 | -11.57 | -13.8% | $84.97 | $87.99 | $71.34 | 16,564,700 | |
| $83.55 | +6.92 | +9.0% | $76.68 | $84.01 | $76.17 | 7,273,900 | |
| $76.63 | +0.13 | +0.2% | $77.36 | $80.31 | $75.80 | 5,685,600 | |
| $76.50 | -5.40 | -6.6% | $81.98 | $82.81 | $75.92 | 7,177,400 | |
| $81.90 | -0.68 | -0.8% | $83.00 | $86.25 | $81.68 | 4,576,100 | |
| $82.58 | -2.50 | -2.9% | $85.49 | $89.09 | $81.78 | 6,288,400 | |
| $85.08 | +0.07 | +0.1% | $83.57 | $86.44 | $82.77 | 6,288,800 | |
| $85.01 | +2.77 | +3.4% | $83.70 | $85.46 | $80.31 | 8,443,100 | |
| $82.24 | +5.65 | +7.4% | $75.69 | $82.46 | $74.81 | 10,821,300 | |
| $76.59 | -0.60 | -0.8% | $76.47 | $78.97 | $75.88 | 5,369,900 | |
| $77.19 | -0.84 | -1.1% | $77.99 | $79.00 | $75.81 | 5,998,200 | |
| $78.03 | +0.19 | +0.2% | $79.08 | $80.25 | $77.13 | 5,633,400 | |
| $77.84 | -2.52 | -3.1% | $81.40 | $81.83 | $75.99 | 9,311,600 | |
| $80.36 | +10.39 | +14.8% | $72.70 | $81.28 | $72.61 | 16,880,400 | |
| $69.97 | +1.12 | +1.6% | $68.79 | $71.48 | $68.42 | 7,585,800 | |
| $68.85 | +6.64 | +10.7% | $61.91 | $68.94 | $61.88 | 8,250,900 | |
| $62.21 | +3.20 | +5.4% | $57.73 | $62.81 | $57.72 | 4,724,200 | |
| $59.01 | +0.27 | +0.5% | $59.47 | $60.38 | $58.48 | 3,690,100 | |
| $58.74 | -2.54 | -4.1% | $59.87 | $61.11 | $58.02 | 5,502,700 | |
| $61.28 | -3.01 | -4.7% | $63.42 | $64.91 | $60.93 | 6,623,800 | |
| $64.29 | -0.33 | -0.5% | $64.04 | $65.79 | $63.21 | 5,187,500 | |
| $64.62 | -0.04 | -0.1% | $64.76 | $66.30 | $63.11 | 4,565,100 | |
| $64.66 | +2.72 | +4.4% | $63.00 | $64.81 | $61.19 | 4,918,400 | |
| $61.94 | -0.33 | -0.5% | $63.15 | $67.10 | $60.06 | 5,785,600 | |
| $62.27 | -0.78 | -1.2% | $65.64 | $65.79 | $61.22 | 6,239,200 | |
| $63.05 | -0.99 | -1.5% | $62.37 | $64.55 | $60.58 | 7,168,800 | |
| $64.04 | -6.65 | -9.4% | $69.05 | $70.90 | $63.77 | 8,774,800 | |
| $70.69 | +2.21 | +3.2% | $68.65 | $71.89 | $67.80 | 6,588,600 | |
| $68.48 | -0.25 | -0.4% | $67.48 | $70.22 | $67.30 | 5,225,800 | |
| $68.73 | +2.56 | +3.9% | $66.58 | $70.79 | $63.61 | 8,882,458 | |
| $66.17 | -6.52 | -9.0% | $70.08 | $72.02 | $65.93 | 11,929,280 | |
| $72.69 | +6.04 | +9.1% | $65.60 | $72.96 | $65.25 | 15,973,100 | |
| $66.65 | +5.40 | +8.8% | $61.83 | $68.96 | $61.70 | 20,144,400 |
- Ticker
- NASDAQ:TEM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Tempus to Present 16 Abstracts at the 2026 San Antonio Breast Cancer Symposium
Latest earnings call · Nov 2, 2026
Tempus AI (NASDAQ:TEM) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 2, 2026
Q3 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Tempus to Present 16 Abstracts at the 2026 San Antonio Breast Cancer Symposium
Nov 19, 2026
Closed $54.04 (-15.1%) on Nov 20, 2026
Tempus to Present Six Abstracts Accepted at the 2026 Connective Tissue Oncology Society Annual Meeting
Nov 11, 2026
Closed $79.43 (-1.4%) on Nov 11, 2026
SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling Cancer
Nov 9, 2026
Closed $80.54 (-4.6%) on Nov 10, 2026
Tempus Reports Third Quarter 2026 Results
Nov 2, 2026
Closed $78.48 (+8.7%) on Nov 2, 2026
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Oct 26, 2026
Closed $67.16 (-0.7%) on Oct 26, 2026
Tempus Expands Strategic Collaboration with Bristol Myers Squibb
Oct 23, 2026
Closed $67.62 (+6.0%) on Oct 23, 2026
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
Oct 19, 2026
Closed $64.34 (-0.6%) on Oct 19, 2026
Tempus to Report Third Quarter 2026 Financial Results on November 2
Oct 15, 2026
Closed $64.72 (-9.0%) on Oct 16, 2026
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
Oct 13, 2026
Closed $68.22 (+0.3%) on Oct 13, 2026
Tempus Announces Multi-Year Collaboration with Moderna and Merck
Oct 7, 2026
Closed $70.35 (-2.3%) on Oct 7, 2026
Tempus AI, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 71 in the last 12 months · 164 in all · newest Nov 19, 2026 · oldest 2024
- Calls
- 10 calls with a replay · 10 with a transcript · latest Nov 2, 2026
- Decks
- 18 decks · latest Nov 2, 2026
Where Tempus AI, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TEM · Home listing · This page | NASDAQ | United States | USD |
| gettex:F3M | gettex | Germany | EUR |
| Tradegate:F3M | Tradegate | Germany | EUR |
| BCBA:TEM | BCBA | Argentina | ARS |
| BOATS:TEM | BOATS | United States | USD |
| BMV:TEM | BMV | Mexico | MXN |
| Lang & Schwarz:A40EDP | Lang & Schwarz | Germany | EUR |
| LS Exchange:A40EDP | LS Exchange | Germany | EUR |
| Milan:1TEM | Milan | Italy | EUR |
| Frankfurt:F3M | Frankfurt | Germany | EUR |
| BX Swiss:TEMUSD | BX Swiss | Switzerland | USD |
| BCBA:TEMC | BCBA | Argentina | USD |
| BCBA:TEMD | BCBA | Argentina | USD |
| BIVA:TEM | BIVA | Mexico | MXN |
| Munich:F3M | Munich | Germany | EUR |
| BX Swiss:TEM | BX Swiss | Switzerland | CHF |
| Dusseldorf:F3M | Dusseldorf | Germany | EUR |
| Hamburg:F3M | Hamburg | Germany | EUR |
| Stuttgart:F3M | Stuttgart | Germany | EUR |
| BCBA:TEM.CI | BCBA | Argentina | ARS |
| Hanover:F3M | Hanover | Germany | EUR |
| Xetra:F3M | Xetra | Germany | EUR |
Valuation
EV/sales 6.0× against a median of 4.3×: 7th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $8.99B USD
- P/E
- Loss
- EV/sales
- 6.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 19.1×
- Gross margin
- Not reported
- Operating margin
- −18.5%
- Net margin
- −12.5%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 2.51
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Tempus AI, Inc. · NASDAQ:TEM | US$9.58B | US$8.99B | n/a | 6.0× | n/a | 19.1× | −12.5% | 0.0× | 2.51 |
| bioMerieux SA · EURONEXT:BIM | US$11.79B | US$11.53B | 27.0× | 2.6× | 10.9× | 2.5× | 9.8% | 0.1× | n/a |
| Bio-Techne Corp · NASDAQ:TECH | US$11.41B | US$11.35B | 66.4× | 9.2× | 33.6× | 5.3× | 14.0% | 0.1× | 0.54 |
| Qiagen N.V. · NYSE:QGEN | US$10.18B | US$11.03B | 24.9× | 5.3× | 15.0× | 3.0× | 19.5% | 0.5× | 0.33 |
| Avantor, Inc. · NYSE:AVTR | US$10.06B | US$13.28B | 29.8× | 2.0× | 14.7× | 1.7× | 5.1% | 0.6× | 0.78 |
| WuXi XDC Cayman, Inc. · HKEX:2268 | US$9.64B | US$8.87B | 43.5× | 10.0× | 33.5× | 5.7× | 24.9% | 0.1× | n/a |
| Bruker Corporation · NASDAQ:BRKR | US$8.62B | US$10.22B | n/a | 2.9× | 64.4× | 3.7× | −3.5% | 0.7× | 1.72 |
| Pharmaron Beijing Co., Ltd. Class A · SZSE:300759 | US$8.52B | US$8.23B | 32.1× | 3.4× | n/a | 3.4× | 11.1% | 0.1× | n/a |
| GenScript Biotech Corporation · HKEX:1548 | US$8.08B | US$7.50B | n/a | 7.8× | 22.8× | 2.1× | −55.5% | 0.1× | n/a |
| Bio-Rad Laboratories, Inc. · NYSE:BIO | US$7.84B | US$7.38B | 7.7× | 2.8× | 71.0× | 1.0× | 39.5% | 0.2× | 0.72 |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A · SZSE:300832 | US$7.51B | US$7.10B | 27.8× | 9.8× | n/a | 5.3× | 37.2% | 0.0× | n/a |
| Median of the others | US$9.13B | US$9.54B | 28.8× | 4.3× | 28.1× | 3.2× | 12.5% | 0.1× | 0.72 |
Forecasts
8 strong buy · 2 buy · 10 hold · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 89.56 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.10 · 13 analysts
- Revenue, year to Dec 2026
- 1.6B · 20 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Eric D. Belcher | Chief Executive Officer, Numerator |
| Eric Lefkofsky | Founder & Chief Executive Officer |
| Jim Rogers | Chief Financial Officer |
| Mike Yasiejko | President, Diagnostics |
| Ryan Fukushima | President, Data & Apps |
| Andy Polovin | Chief Legal Officer |
| Caroline Corner | Investor Relations |
| Elizabeth Krutoholow | Tempus Investor Relations |
| Chris Scotto DiVetta | SVP & GM, AI Applications |
| Christina Antoniou | SVP, Head of Corporate Development |
| Erik Phelps | EVP & Chief Administrative & Legal Officer |
| Lauren Silvis | SVP, External Affairs |
| Razik Yousfi | SVP & GM, AI Products |
| Ezra Cohen | Chief Medical Officer, Data & Apps |
| Greg Fisbeck | Chief Information Security Officer |
| Jennifer A. Doudna | Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute |
| Kate Sasser | Chief Scientific Officer |
| Laura Elster | Chief Commercial Officer, Diagnostics |
| Melisa Tucker | Chief Data Officer |
| Robyn Eckerling | Chief Privacy Officer |
| Shane Colley | Chief Technology Officer |
| Shane Woods | Chief Strategy Officer & GM, Data Products |
| Stacey Kraft | Chief People Officer |
| Ted Leonsis | Cofounder & Partner, Revolution Growth |
| TJ Slavin | Chief Medical Officer, Diagnostics |
Board
| Director | Role |
|---|---|
| Peter J. Barris | Chairman & General Partner, New Enterprise Associates |
| David Epstein | Director |
| Eric D. Belcher | Chief Executive Officer, Numerator |
| Eric Lefkofsky | Founder & Chief Executive Officer |
| Jennifer A. Doudna | Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute |
| Nadja West | Director |
| Scott Gottlieb | Director |
| Theodore J. Leonsis | Director |
| Wayne A.I. Frederick | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Tempus AI (NASDAQ:TEM) Q3 2026 Earnings Call | Mon, Nov 02, 2026 · 8:45 AM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q1 2026 Earnings Call | Tue, May 05, 2026 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q2 2025 Earnings Call | Fri, Aug 08, 2025 · 8:00 AM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q1 2025 Earnings Call | Tue, May 06, 2025 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q4 2024 Earnings Call | Mon, Feb 24, 2025 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q3 2024 Earnings Call | Mon, Nov 04, 2024 · 4:30 PM ET | Replay |
| Tempus AI (NASDAQ:TEM) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 2, 2026 · Before open | +8.7% |
| Q2 2026 | Jul 30, 2026 · After close | −0.9% |
| Q1 2026 | May 5, 2026 · After close | −1.1% |
| Q4 2025 | Mar 2, 2026 | −3.5% |
| Q3 2025 | Nov 4, 2025 · After close | −2.6% |
| Q2 2025 | Aug 8, 2025 · Before open | +3.6% |
| Q1 2025 | May 6, 2025 · After close | +12.6% |
| Q4 2024 | Feb 24, 2025 | −13.2% |
| Q3 2024 | Nov 4, 2024 · After close | −10.1% |
| Q2 2024 | Aug 6, 2024 · After close | −4.5% |
All 11 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 29, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 24 slides | Nov 2, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 26 slides | Jul 30, 2026 |
| Merger or Acquisition (July 2026) | Merger or acquisition | 11 slides | Jul 20, 2026 |
| ESMO Congress 2025 | Conference | 12 slides | October 2025 |
| Technical Presentation (September 2025) | Technical | 12 slides | September 2025 |
| Q2 2025 Earnings Presentation | Earnings | 30 slides | Aug 8, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 30 slides | May 6, 2025 |
| Technical Presentation (May 2025) | Technical | 13 slides | May 2025 |
| Technical Presentation (March 2025) | Technical | 14 slides | March 2025 |
| Technical Presentation (November 2024) | Technical | 13 slides | November 2024 |
All 18 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (October 2023) | Technical | 7 slides | October 2023 |
| TCT 2023 | Conference | 7 slides | October 2023 |
| Technical Presentation (2023) | Technical | 7 slides | 2023 |
| Technical Presentation (2023) | Technical | 22 slides | 2023 |
| Technical Presentation (November 2022) | Technical | 19 slides | November 2022 |
| ESMO GI 2022 | Conference | 22 slides | Jul 1, 2022 |
| Technical Presentation (December 2021) | Technical | 14 slides | Dec 7, 2021 |
| Tempus Labs — Technical Presentation (December 2021) | Technical | 5 slides | December 2021 |
Financings
| Raise | Date |
|---|---|
| 0.0% convertible senior notes due 2032 Closed: US$460M raised | Jul 30, 2026 |
| 0.75% convertible senior notes Closed: US$750M raised Use of proceeds: Strengthen the balance sheet and replace a portion of the existing term loan with lower-interest debt | Aug 8, 2025 |
| Convertible Senior Notes due 2030 Announced: US$400M Use of proceeds: Repay $274.7 million of senior secured term loans, pay for capped call transactions, and general corporate purposes | Jun 30, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$37.00 a share on Jun 13, 2024.
- Price
- US$37.00 a share
- Shares offered
- 11,100,000 shares of Class A common stock
- Offering size
- US$410.7 million
- Underwriters' option
- Up to 1,665,000 more shares
- Underwriters
- MORGAN STANLEY, J.P. MORGAN, ALLEN & COMPANY LLC, BofA SECURITIES, TD COWEN, STIFEL, WILLIAM BLAIR, LOOP CAPITAL MARKETS, NEEDHAM & COMPANY · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 1, 2021 |
| Filed publicly | May 20, 2024 |
| Amended twice | Newest Jun 13, 2024 |
| Shares registered with an exchange | Jun 11, 2024 |
| Declared effective by the SEC | Jun 13, 2024 |
| Final prospectus, with the price | Jun 17, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 17, 2024 |
| EFFECT · Notice that a registration is effective | Jun 13, 2024 |
| S-1/A · Registration statement, amended | Jun 13, 2024 |
| CERT · Exchange's certificate of listing | Jun 12, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 11, 2024 |
| CORRESP · Letter to the SEC | Jun 11, 2024 |
| CORRESP · Letter to the SEC | Jun 11, 2024 |
| S-1/A · Registration statement, amended | Jun 5, 2024 |
| S-1 · Registration statement | May 20, 2024 |
| DRS/A · Draft registration statement, amended | Feb 28, 2024 |
All 41 filings
Open IPO · From the cover of the final prospectus (424B4) filed Jun 17, 2024
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.27B | 693.4M | 531.8M | 320.7M |
| Research and development | 172.9M | 149.3M | 90.3M | 83.2M |
| Selling, general and administrative | 731.7M | 755.4M | 296.8M | 233.4M |
| Operating income | -252.9M | -691.1M | -196.1M | -265.4M |
| Depreciation and amortization | 32.1M | 26.4M | 21.3M | 16.7M |
| EBITDA | -220.8M | -664.7M | -174.8M | -248.7M |
| Interest expense | 70.3M | 53.7M | 46.9M | 21.9M |
| Income before tax | -291.1M | -701.3M | -213.5M | -289.1M |
| Income tax | -51.7M | 266.0K | 288.0K | 66.0K |
| Net income | -245.0M | -705.8M | -214.1M | -289.8M |
| Earnings per share, basic | -1.41 | -6.23 | -4.20 | -5.30 |
| Earnings per share, diluted | -1.41 | -6.23 | -4.20 | -5.30 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 604.8M | 341.0M | 165.8M | 302.9M |
| Receivables | 311.2M | 154.8M | 94.5M | |
| Inventory | 51.7M | 38.4M | 28.8M | |
| Current assets | 1.17B | 667.6M | 350.3M | |
| Property, plant and equipment | 89.2M | 58.1M | 61.7M | |
| Goodwill | 470.2M | 73.3M | 73.4M | 53.1M |
| Total assets | 2.27B | 926.1M | 564.1M | |
| Accounts payable | 82.0M | 53.8M | 54.4M | |
| Current liabilities | 372.4M | 291.1M | 232.6M | |
| Total liabilities | 1.78B | 869.8M | 840.7M | |
| Shareholders' equity | 491.3M | 56.3M | -1.38B | -1.13B |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -218.1M | -189.0M | -214.3M | -168.2M |
| Capital spending | -21.0M | -22.1M | -34.6M | -18.4M |
| Free cash flow | -239.1M | -211.2M | -248.9M | -186.6M |
| Cash from investing | -398.4M | -130.4M | -40.3M | -57.9M |
| Cash from financing | 884.1M | 494.3M | 117.5M | 251.4M |
| Dividends paid | 0 | -5.63M | -5.63M | -5.63M |
| Change in cash | 267.6M | 175.2M | -137.1M | 25.3M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 19, 2026 | Other filings | SEC |
| 8-K · Current report | Nov 18, 2026 | Material contract | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 2, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 2, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 2, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 29, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 28, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Oct 27, 2026 | Other filings | SEC |
| 8-K · Current report | Oct 23, 2026 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Oct 22, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Oct 21, 2026 | Offer document | SEC |
| S-4/A · Registration statement, amended | Oct 20, 2026 | Offer document | SEC |
| S-4/A · Registration statement, amended | Oct 2, 2026 | Offer document | SEC |
| 4 · Change in ownership | Sep 29, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 24, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 22, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 17, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 16, 2026 | Other filings | SEC |
| 425 | Sep 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 1, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 1, 2026 | Insider trade | SEC |
| S-4 · Registration statement | Aug 31, 2026 | Offer document | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 14, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 7, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Jul 28, 2026 | Other filings | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jul 21, 2026 | Big-stake notice | SEC |
| 425 | Jul 20, 2026 | Other filings | SEC |
| 425 | Jul 20, 2026 | Other filings | SEC |
| 425 | Jul 20, 2026 | Other filings | SEC |
| 425 | Jul 20, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 20, 2026 | Material contract | SEC |
| 425 | Jul 20, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 20, 2026 | Current report | SEC |
| 4 · Change in ownership | Jul 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 29, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 29, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 25, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 27, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 8-K · Current report | May 22, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 20, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 8-K · Current report | May 12, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 6, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 28, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 15, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 7, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 7, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 7, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 27, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Mar 26, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Mar 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Feb 25, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 24, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 10, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 28, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 18, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 16, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 20, 2025 | Other filings | SEC |
This page holds 200 of 525 filings. Open Filings
Cap table
Built by 6ix from Tempus AI, Inc.’s releases · as of Jul 30, 2026
- Common shares
- 177,357,848
- Fully diluted
- 177,357,848
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 177,357,848 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 177,357,848 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Barris Other companies: Sprout Social, Inc (Lead Independent Director · Since at least Dec 12, 2019); ZeroFox Holdings Inc. (Director · Aug 3, 2022 – Dec 14, 2022 · Past); NextNav Inc. (Director · Oct 28, 2021 – Jun 22, 2022 · Past); Berkshire Grey Inc (Director · Jul 21, 2021 – Jul 20, 2023 · Past); Groupon, Inc. (Director · Apr 21, 2016 – Jul 21, 2022 · Past) | Chairman & General Partner, New Enterprise Associates · Since at least Jun 13, 2024 |
| Scott Gottlieb Other companies: UnitedHealth Group Incorporated (Director · Since at least Nov 18, 2025); Illumina, Inc. (Chair of the Board · Since at least Feb 4, 2020); Pfizer, Inc. (Director · Since at least Jun 27, 2019); Targeted Medical Pharma Inc (Director · Jul 22, 2013 – Jul 22, 2013 · Past); CombiMatrix Corp (Director · Jan 15, 2009 – May 9, 2016 · Past) | Director · Since at least Jun 13, 2024 |
| Wayne A.I. Frederick Other companies: Humana Inc. (Director · Since at least Dec 31, 2022); Workday, Inc. (Independent Director · Since at least Jun 22, 2022); Insulet Corporation (Director · Since at least May 24, 2022); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Oct 14, 2022 · Past) | Director · Since at least Jun 13, 2024 |
| David R. Epstein Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Pfizer, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past); Seagen Inc (CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past) | Director · Since at least Jun 13, 2024 |
| Nadja West Other companies: Johnson & Johnson (Director · Since at least Dec 3, 2020); Tenet Healthcare Corporation (Director · Since at least Oct 8, 2019); Nucor Corporation (Director · Since at least Sep 5, 2019) | Director · Since at least Jun 13, 2024 |
| Theodore Leonsis Other companies: Groupon, Inc. (Chairman · Since at least Nov 3, 2011); American Express Company (Director · Since at least Jul 19, 2010); Rosetta Stone Inc (Director · Dec 7, 2009 – May 23, 2012 · Past) | Director · Since at least Jun 13, 2024 |
| Eric Belcher Other companies: InnerWorkings Inc (Director · Aug 15, 2006 – Dec 31, 2018 · Past) | Chief Executive Officer, Numerator · Since at least Jun 13, 2024 |
| Andrew Polovin | EVP, Chief Legal Officer · Since at least Jun 13, 2024 |
| Andy Polovin | Chief Legal Officer · Since at least Sep 18, 2026 |
| Caroline Corner | Investor Relations · Since at least Jul 20, 2026 |
All 35 people
| Person | Seat |
|---|---|
| Chris Scotto DiVetta | SVP & GM, AI Applications · Since at least Sep 11, 2025 |
| Christina Antoniou | SVP, Head of Corporate Development · Since at least Nov 4, 2026 |
| Elizabeth Krutoholow | Tempus Investor Relations · Since at least May 29, 2026 |
| Eric Lefkofsky | Founder & Chief Executive Officer · Since at least Apr 28, 2026 |
| Erik Phelps | EVP & Chief Administrative & Legal Officer · Since at least Nov 4, 2026 |
| Ezra Cohen | Chief Medical Officer, Data & Apps · Since at least Oct 19, 2026 |
| Greg Fisbeck | Chief Information Security Officer · Since at least Nov 4, 2026 |
| James William Rogers | Chief Financial Officer · Since at least Jun 13, 2024 |
| Jennifer Doudna | Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute · Since at least May 21, 2026 |
| Jim Rogers | Chief Financial Officer · Since at least Aug 20, 2026 |
| Kate Sasser | Chief Scientific Officer · Since at least May 29, 2026 |
| Laura Elster | Chief Commercial Officer, Diagnostics · Since at least May 21, 2026 |
| Lauren Silvis | SVP, External Affairs · Since at least Oct 26, 2026 |
| Melisa Tucker | Chief Data Officer · Since at least Nov 4, 2026 |
| Mike Yasiejko | President, Diagnostics · Since at least May 20, 2025 |
| Razik Yousfi | SVP & GM, AI Products · Since at least Aug 4, 2026 |
| Robyn Eckerling | Chief Privacy Officer · Since at least Nov 4, 2026 |
| Ryan Fukushima | President, Data & Apps · Since at least Jun 13, 2024 |
| Ryan M Bartolucci | Chief Accounting Officer · Since at least May 4, 2026 |
| Shane Colley | Chief Technology Officer · Since at least May 27, 2026 |
| Shane Woods | Chief Strategy Officer & GM, Data Products · Since at least Nov 4, 2026 |
| Stacey Kraft | Chief People Officer · Since at least Nov 4, 2026 |
| Ted Leonsis | Cofounder & Partner, Revolution Growth · Since at least Nov 4, 2026 |
| Thomas Edward Schoenherr | CEO, Diagnostics · Since at least Feb 20, 2026 |
| TJ Slavin | Chief Medical Officer, Diagnostics · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Tempus AI, Inc.